International Journal of Advance Research in Nursing
2019, Vol. 2, Issue 1, Part A
Effectiveness of guided imagery on depression among cancer patients
A pre and post test with control group experimental design was undertaken on 60 cancer patients selected by purposive sampling in a selected private hospital, Salem, to assess the significance of Guided imagery on depression among cancer patients. Data was collected by the investigator herself from 01.12.2015 to 31.12.2015. Demographic characteristics reveals that highest percentage of patients in control (47%) and experimental (33%) group were in the age group of 30 – 40 years and 40 – 50 years respectively. Most of them had higher education, house wives, married, belonged to low income family, joint family and had no previous exposure to imagery. Overall observation during pretest shows that around 50% of the patients in control group (50%) and experimental group (53%) had severe level of depression. Twenty three percentage of the experimental group and 30% of the control group respectively had moderate and mild level of depression. Only 3% of the control group had no depression. However, during post test highest percentage (48%) of women in control group had severe depression whereas in experimental group 45% had mild depression. Only 13% of the experimental group had no depression. Comparison of level of depression among cancer patients in pretest and post test in experimental group with their demographic variables reveals that higher percentage of depression was mild irrespective of their age, education, occupation, marital status, family income percapita, type of family and previous exposure to yoga. Significant (P<0.05) association was found between level of depression among cancer patients in experimental group during post test. No significant association (p>0.05) was found between level of depression among cancer patients in experimental group during post test with their demographic variables except their education. It seems that Guided imagery was effective in reduce the level of depression among cancer patients.